Viridian Therapeutics, Inc.\DE (VRDN) Debt Ratio (2013 - 2026)

Viridian Therapeutics, Inc.\DE's Debt Ratio history runs 12 years deep, the most recent figure standing at 0.05 for Q1 2026.

• In Q1 2026, Debt Ratio rose 46.17% year-over-year to 0.05; the TTM figure through Mar 2026 stood at 0.05 (up 46.17% YoY), while the FY2025 annual figure was 0.04, changed N/A from the prior year.
• Debt Ratio for Q1 2026 stood at 0.05, up from 0.04 in the prior quarter.
• The five-year high for Debt Ratio was 0.06 in Q3 2023, with the low at 0.01 in Q3 2022.
• The 5-year median for Debt Ratio is 0.03 (2024), against an average of 0.03.
• The sharpest annual moves came in 2023 and 2024: Debt Ratio soared 481.03% in 2023, then tumbled 56.3% in 2024.
• Viridian Therapeutics, Inc.\DE's Debt Ratio stood at 0.01 in 2022, then jumped by 285.91% to 0.04 in 2023, then sank by 35.47% to 0.03 in 2024, then soared by 43.2% to 0.04 in 2025, then gained by 20.14% to 0.05 in 2026.
• Business Quant data shows VRDN's Debt Ratio at 0.05 in Q1 2026, 0.04 in Q4 2025, and 0.04 in Q3 2025.